Additional European Equity News

AstraZeneca (AZN LN) - Co.'s Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD, demonstrating a statistically significant and clinically meaningful reduction in the annualised rate of moderate-to-severe COPD exacerbations in the primary population of former smokers and in the overall population. (AstraZeneca)

Eni (ENI IM) - Co. announces a new gas discovery in the Kutei Basin, offshore Indonesia. Preliminary estimates indicate in-place resources of approximately 5Tcf of gas and 300mln barrels of condensate in the encountered interval. (Eni)

Evoke (EVOK LN) - Confirms it is in discussions with Bally's Intralot (BALY) regarding a possible offer for the entire issued and to be issued share capital of the Company at a price of 50 pence per share. The Proposal is expected to comprise an all-share combination with a partial cash alternative. There can be no certainty that an offer will be made or as to the terms on which any offer might be made. (Evoke) 

Ferrexpo (FXPO LN) - Q1 2026 Production Report: Total commercial production 592,751, -72% Y/Y. As previously announced, production activities were largely suspended in Q1 due to nationwide attacks on Ukrainian electricity generation and transmission infrastructure. CEO: “Fortunately in late February we saw sufficient improvements in the availability and price of electricity to restart limited production at FPM on one pellet line. One pellet line remains in operation, and the Group continues to use its own fleet of rail wagons to export to customers in Eastern and Central Europe”. Confirms need for a capital equity raise, likely to need USD 100mln. (Ferrexpo) 

GSK (GSK LN) - Co.'s Blenrep has been approved in China for treatment of 2L+ relapsed/refractory multiple myeloma. Blenrep combination showed a 42% reduction in risk of death and nearly tripled median progression-free survival versus a daratumumab-based triplet. (GSK) 

Heidelberg Materials (HEI GY) - Co. to increase its existing shareholding in Akçansa from 39.72% to 79.44%, significantly strengthening its strategic position in Turkey and the Mediterranean Basin. (Heidelberg Materials) 

Plus 500 (PLUS LN) - Q1 2026 (USD): Revenue 242.1mln (prev. 205.8mln Y/Y), EBITDA 95.7mln prev. 93.8mln Y/Y). Reflecting strong performance and outlook, the Board expects FY 2026 revenue and EBITDA to be ahead of current market expectation. (Plus 500) 

Repsol (REP SM) - Co. is to claim EUR 125mln from Iderdrola (IBE SM), Endesa (ELE SM) and Naturgy, in which the Co. was affected following the 2025 blackout. (Expansion)

Trade - US trade officials are considering tougher USMCA auto import rules, including a revision to the minimum auto parts threshold to boost the domestic industry.

UK Politics - Manchester Mayor Burnham met with Former Deputy PM Rayner on Friday, "Revelation will fuel rumours they are hatching a plot & the PM could face a leadership challenge", according to the Sun (Sun)

AB SKF (SKFB SS) downgraded to Sector Perform from Outperform at RBC

Subsea 7 (SUBC NO) downgraded to Equal Weight from Overweight at Barclays

Technip Energies (TE FP) upgraded to Overweight from Underweight at Barclays

20 Apr 2026 - 07:17- EnergyEU Research- Source: Newsquawk